Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Fysieke activiteit geassocieerd met overleving gemetastaseerd colorectaal carcinoom
nov 2019 | Maag-darm-leveroncologie